Summary:
- Recent clinical data suggests that GLP-1 receptor agonists, such as semaglutide, may provide health benefits beyond weight loss and diabetes management, potentially reducing systemic inflammation and oxidative stress.
- Researchers are investigating whether these pharmacological interventions can slow the biological aging process and extend overall healthspan by mitigating age-related chronic diseases like cardiovascular conditions and neurodegeneration.